… of instituting neoadjuvant therapy in patients with stage IIlb non-… and radiation therapy for
stage IIIA carcinoma of the lung. … with surgery alone in resectable stage IIIA non-small cell lung …

… Of the 82 patients studied, 34 received neoadjuvant therapy, 48 received conventional …
the stage IIIB and 22 per cent of the stage IIIA patients received neoadjuvant therapy. In the …

… neoadjuvant chemotherapy with or without radiation. The timing of an operation after therapy
… of intervention after neoadjuvant therapy and the impact on outcomes in this demographic. …

… Znntrodzlction: Neoadjuvant therapy in patients with Stage IIIA NSCLC is associated with a
… The regimen was therefore evaluated in 34 patients with pathologic Stage IIIA N2 disease …

… It has been suggested that a possible overall survival advantage of neoadjuvant therapy
in stage IIIA NSCLC in INT-0139 was diluted by the unusually high mortality rate in patients …

… and adjuvant erlotinib with platinum-doublet chemotherapy in 72 patients with stage IIIA–N2
EGFR-mutated NSCLC. Although this study did not meet its primary endpoint of objective …

… (59 men) with stage IIIA N2-positive NSCLC received neoadjuvant therapy before surgical
… Our results show that surgical resection after induction therapy for N2-positive stage IIIA …

… whether neoadjuvant erlotinib improves operability and survival in patients with stage IIIA‐…
in patients with stage IIIA‐N2 NSCLC. In a study by Noh et al., 52.3% of patients with …

Purpose: The role of targeted therapy in the neoadjuvant field of stage IIIA epidermal growth …
and safety of neoadjuvant targeted therapy (NTT) with neoadjuvant chemotherapy (NCT) …

… In addition, we included only patients who underwent surgery after neoadjuvant therapy,
and therefore the results cannot be generalized to all patients with stage IIIA-N2 NSCLC given …